International Clinical Trial: Randomized controlled, multicenter, phase III clinical study evaluating the efficacy and safety of moderate-fractionated radiotherapy as adjuvant therapy for early-stage squamous cell carcinoma with only intermediate-risk factors after radical surgery for cervical cancer

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121842) titled 'Randomized controlled, multicenter, phase III clinical study evaluating the efficacy and safety of moderate-fractionated radiotherapy as adjuvant therapy for early-stage squamous cell carcinoma with only intermediate-risk factors after radical surgery for cervical cancer' on April 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Fudan University Shanghai Cancer Center

Condition: Cervical cancer

Intervention: Experimental group:Medium-fractionated radiotherapy is applied as adjuvant therapy for early squamous cell carcinoma with only moderate-risk factors after radical surgery fo...